« Back to Record
Pita, J. M., Raspé, E., Coulonval, K., Decaussin-Petrucci, M., Tarabichi, M., Dom, G., Libert, F., Ruscas-Craciun, L. I., Andry, G., Wicquart, L., Leteurtre, E., Tresallet, C., Marlow, L. A., Copland, J. A., Durante, C., Maenhaut, C., Cavaco, B. M., Dumont, J. E., Costante, G., & Roger, P. P. (2023). CDK4 phosphorylation status and rational use for combining CDK4/6 and BRAF/MEK inhibition in advanced thyroid carcinomas. Frontiers in endocrinology, 14, 1247542. doi:10.3389/fendo.2023.1247542
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/365060



